| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
3,234 |
2,911 |
$192K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
57 |
42 |
$88K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
741 |
657 |
$62K |
| 80053 |
Comprehensive metabolic panel |
2,868 |
2,437 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,595 |
4,656 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
285 |
279 |
$12K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
973 |
624 |
$7K |
| 96367 |
|
347 |
303 |
$6K |
| J1750 |
Injection, iron dextran, 50 mg |
27 |
27 |
$4K |
| 99245 |
|
12 |
12 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40 |
38 |
$1K |
| 96417 |
|
13 |
12 |
$937.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,283 |
842 |
$840.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
70 |
$787.38 |
| 82728 |
|
56 |
55 |
$562.25 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
31 |
29 |
$417.61 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
377 |
268 |
$194.59 |
| 83540 |
|
14 |
14 |
$118.75 |
| 83550 |
|
14 |
14 |
$70.25 |
| 36415 |
Collection of venous blood by venipuncture |
156 |
130 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
60 |
56 |
$0.00 |